Investing in Johnson & Johnson
Johnson & Johnson has been a part of people's lives for more than 120 years and a valuable part of their investments for more than 60 years. Founded in 1886, we listed our shares on the New York Stock Exchange for public investors in 1944.
During our history, we have built the most comprehensive base of health care businesses in the world, generating more than 70 percent of our revenues from No. 1 or No. 2 global leadership positions in our respective markets.
Our consistent performance has enabled us to deliver an exceptional track record of growth that few, if any, companies can claim: 76 consecutive years of sales increases; 25 consecutive years of adjusted earnings increases; and 47 consecutive years of dividend increases. Over the last 10 years, Johnson & Johnson stock generated a 5.6 percent total return for investors compared to a -1.4 percent total return for the S&P 500.1
Our consumer products, pharmaceuticals, medical devices and diagnostics play a role in helping millions of people be well and stay well every day. We remain committed to improving the health and well-being of people everywhere, profitably growing our businesses, and enhancing the value we can bring to our shareholders.
Investor News
November 5, 2009
Johnson & Johnson to Participate in Credit Suisse 18th Annual Health Care Conference
November 3, 2009
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth
October 22, 2009
Xerox Chairman Anne M. Mulcahy Appointed to Johnson & Johnson Board of Directors
Investor Communications
Financial Quick Links
Q3 2009 Earnings Announcement
Q3 2009 Sales of Key Products/Franchises
Investor Facts
5 Year Financial Review
1. Data source - Bloomberg